AlphaFold 3, the improved version of the model used by Isomorphic Labs’ drug design engine, debuted last May. It can predict the shape of not only proteins but also DNA, RNA and other biological building blocks. Moreover, the algorithm does so more reliably than earlier models.

Isomorphic Labs says it is advancing drug design programs across multiple therapeutic areas and drug modalities. These include oncology and immunology, the primary focuses of the company's internal programs.